Securities fraud litigation history and active cases
In Litigation
0
Settlement
0
Closed
2
Total Settlement
$0
8:25cv2581 • August 5, 2025
Class Period Start
August 10, 2023
Class Period End
June 25, 2025
PSLRA Deadline
October 6, 2025
Case Allegations
10b5
Statutes of Repose
Aug 10, 2026
Country
United States
Court
Federal Court
Nov 26, 2025
Voluntary Dismissal
The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.
Oct 17, 2025
Appointment of Lead Plaintiff
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Aug 5, 2025
First Filed Complaint
A securities fraud class action complaint has been filed on behalf of certain investors in Altimmune, Inc..
8:24cv1315 • May 6, 2024
Class Period Start
December 1, 2023
Class Period End
April 26, 2024
PSLRA Deadline
July 5, 2024
Case Allegations
10b5
Statutes of Repose
Dec 1, 2026
Country
United States
Court
Federal Court
Dec 16, 2024
Voluntary Dismissal
The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.
Oct 2, 2024
Appointment of Lead Plaintiff
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Jul 1, 2024
Additional Complaint
Another plaintiff has filed a complaint on behalf of investors in Altimmune, Inc.. The allegations and class definitions are substantively the same.
May 6, 2024
First Filed Complaint
A securities fraud class action complaint has been filed on behalf of certain investors in Altimmune, Inc..
TOP
